Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus supportive psychotherapy for anxiety and depression in adults with leukemia
IRCT20180425039418N4Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sertraline in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Rate of anxiety, Rate of depression and 2 more. Started Dec 2018; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on IRCT20180425039418N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180425039418N4.